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* Corresponding author. Tel.: +972 2 2982037; fax:
E-mail address: latif@birzeit.edu (A.L. Abuhijleh).The dinuclear complex tetra(l-valproato) dirhodium(II), Rh2(valp)4 (1), and its bis-adducts with theoph-
ylline, Rh2(valp)4(ThH)2 (4), or caffeine, Rh2(valp)4(Caf)2 (5), have been synthesized and characterized by
elemental analysis, IR, UV–Vis, magnetic moment, 1H and 13C NMR spectroscopic techniques. Spectral
data for the complexes are consistent with a dinuclear structure as found for rhodium (II) tetracarboxyl-
ate adducts. Theophylline and caffeine bases in complexes 4 and 5, respectively, are axially coordinated
to rhodium (II) atoms through the sterically hindered N(9) site. This is conﬁrmed by X-ray crystal struc-
ture analyses of complexes 4 and 5.
 2009 Elsevier B.V. All rights reserved.1. Introduction
The coordination chemistry of the dinuclear tetracarboxylate
complexes of the transition metals are a focus of interest owing
to their wide application in many ﬁelds, such as material science,
catalysis and as anticancer agents [1–8]. Among the compounds
that have been investigated as antitumor agents were dirhodium
tetracarboxylate complexes. The antitumor activity of these com-
plexes was ﬁrst discovered by Bear et al. [4,5] and it was found that
the activity of dirhodium tetracarboxylate, Rh2(OOCR)4, to be in the
order: methoxyacetate < acetate < propionate < butyrate [5]. The
ability of these complexes to function as antitumor agents against
many types of tumors, by inhibiting DNA and protein synthesis,
has prompted several studies on the nature of rhodium carboxyl-
ates formed with various nucleic acids and their constituent bases
in order to elucidate their inhibition properties [1,2,8–24]. These
investigations have shown that dirhodium tetracarboxylates form
stable mono and bis-adducts as well as bridging and/or chelating
adducts with a wide variety of ligand types involving donor atoms
such as nitrogen, oxygen and sulfur [1,2,8–24]. X-ray crystal struc-
ture analyses of tetrakis(-l-acetato)dirhodium(II) complexes of
theophylline and caffeine have shown that in both complexes theAll rights reserved.
+972 2 281 0656.dirhodium–tetra-acetate nucleus is occupied at the two axial posi-
tions by N(9) of the theophyline and caffeine bases [9].
Valproic acid (2-propylpentanoic acid) (CH3CH2CH2)2CHCOOH,
in the form of its sodium salt has a wide spectrum of activity as
an anticonvulsant drug [25]. The interaction of this drug with tran-
sition metal ions is only known for copper (II) [26]. We prepared
several mononuclear and binuclear copper (II) valproate com-
plexes with nitrogen donor ligands and studied their biological
activities [27–29]. The present work was undertaken as part of
our study of the interaction of the valproate drug with other tran-
sition metals. And since the antitumor activity of dirhodium tetra-
carboxylate may increase with increasing the number of carbon
atoms in the carboxylate ion, we extended the interaction of the
valproate drug with rhodium (II). We report here the synthesis
and spectroscopic characterization of dirhodium (II) tetravalproate
and it adducts with theophylline and caffeine and determined
crystal structures of these adducts, Scheme 1.
Theophylline (2) is chosen as a ligand since it has the same
N(7)/O(6) arrangement as guanine. The N(7)/O(6) portion of guan-
ine is the region of DNA which has been discussed in reference to
heavy metal–DNA interactions. [9,13,30]. Caffeine (3) [where N(7)
is blocked] was chosen to compare its coordination site with that
of theophylline. In addition, theophylline and caffeine are purine
alkaloids possessing several pharmacological properties and their
interactions with metals ions gain importance in bioinorganic
chemistry.
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82. Results and discussion
Results of elemental analyses for the complexes comply with
the formula Rh2(valp)4 or Rh2(valp)4L2, when L = theophylline
(ThH) or caffeine (Caf). The binary and ternary complexes are sol-
uble in several polar solvents such as diethyl ether (binary com-
plex), chloroform, dichloromethane, acetone, and methanol.
2.1. Infrared spectra
The assignments of IR frequencies for the asymmetrical stretch,
masym(CO2), and the symmetrical stretch, msym(CO2), of the valproate
group are given in Table 1. The masym(CO2) vibrations for the rho-
dium valproate and its adducts occur between 1565 and
1585 cm1 and msym(CO2) vibrations occur at about 1413 cm1.
The values of the difference between masym(CO2) and msym(CO2)Table 1
Visible and IR spectral data for the complexes.
Compound kmax (nm) (? = dm3 mol1 cm1)
Band I Band II
1 612 (250) 442 (110)
4 566 (245) 443 (150)
5 565 (256) 442 (155)
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Scheme 1. Syntheses of theDm = 151–172 cm1, are consistent with a bidentate bridging mode
for the carboxylates [31]. These IR results agree well with those ob-
served in dimeric rhodium complexes of other alkyl carboxylates,
[1] in which the carboxylate acts as a ‘‘bridging” bidentate ligand.
An increase in the masym(CO2) values for bis-adducts 4 and 5 in
comparison to the corresponding value for the binary complex 1
is due to axial coordination of donor base ligands in these adducts
[1,2].
In theophylline and caffeine complexes 4 and 5, respectively,
the two C@O (at positions 2 and 6) stretching vibrations of these
purines found at about 1710–1712 and 1665–1675 cm1. This
indicates that the exocyclic oxygens at positions 2 and 6 do not
participate in coordination since the corresponding vibrations for
free purine occurs at about 1712–1718 and 1670–1680 cm1.
Coordination through one of these oxygens may cause a shift to
lower energy by about 40–50 cm1 for the carbonyl group of the
ligand [32]. The m(C@N) ring vibration for these free purines occurs
at about 1570 cm1 is shifted to lower value at about 1550 cm1
upon the bis-adducts formation may suggest that the coordination
of these purines is through imidazole ring.
2.2. Electronic absorption spectra
Electronic absorption spectral data of the complexes in CH2Cl2
solutions are given in Table 1. These complexes show two charac-
teristic absorption bands in the visible region. The lower energymasym (CO2) (cm1) msym (CO2) (cm1) Dm (cm1)
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1582 1413 169
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complexes 1, 4 and 5.
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and the higher energy band (II) as the p*(RhRh)? r*(Rh–O)
[1,14,33], or as the p(Rh–O)? r*(Rh–O) transition [37]. Band I
shows blue shift when dirhodium tetracarboxylate complex is coor-
dinated to a stronger axial ligand compared with the absorption
peak of Rh2(O2CCR)4 without any axial ligands [33]. In addition,
the nature of the axial ligand deﬁnes the apparent color of the ad-
duct. The adducts formed are green or blue-green for oxygen donor
ligands, rose-red, violet, purple or pink for nitrogen donors, and vio-
let, purple, or orange for sulfur donors [35]. The purple or violet col-
or and the shift of the absorption peak of band I to higher energy for
the bis-adducts 4 and 5 compared with the absorption peak of the
binary Rh2(valp)4 complex (Table 1) is in agreement with an axial
nitrogen donor ligands [1,14]. Band II in the visible region of dirho-
dium tetracarboxylates does not depend on the nature of axial li-
gands but it depends on the nature of the equatorial ligands, i.e.
the nature of the carboxylate group [1]. For the complexes under
investigation, the energy of this band remains essentially constant
(Table 1) around 442 nm. These spectral results are consistent with
the presence of four bridging valproate groups in equatorial posi-
tions of dirhodium (II) atoms in the binary and ternary adducts,
while the nitrogen donor ligands are occupying the axial positions
in the ternary bis-adducts with theophylline or caffeine.
2.3. Magnetic moment
The magnetic moments (leff), which were calculated from the
magnetic susceptibilities, are those for diamagnetic compounds.
They are in the same range of other dinuclear rhodium (II) carbox-
ylates having r2 p4 d2 p*4 d*2 electronic conﬁguration with a single
bond between the two rhodium (II) atoms, such as the well-knownTable 2
13C NMR (CDCl3) chemical shifts (ppm).
Compound N1–CH3 N3–CH3 N7–CH3
ThH (2) 28.53 30.28 –
Rh2(valp)4(ThH)2 (4) 29.05 31.60 –
Dd 0.52 1.32 –
Caf (3) 27.94 29.76 33.60
Rh2(valp)4(Caf)2 (5) 28.20 30.71 34.10
Dd 0.26 0.95 0.50
Dd is the chemical shift difference between coordinated ligand to rhodium and free liga
Fig. 1. View of the molecular structure of 4, showing the atom numbering scheme. Elrhodium (II) acetate and its bis-adducts [1], indicating the exis-
tence of the same dinuclear structure in the present rhodium (II)
valproate complexes. The two rhodium (II) atoms are bridged by
four valproate groups, without donor base ligands in the axial posi-
tions, compound 1, or the axial positions are occupied by purine
molecules, compounds 4 and 5.
2.4. 1H and 13C Nuclear magnetic resonance
Proton NMR spectrum of Rh2(valp)4 in CDCl3 shows triplet of
CH3 groups centered at 0.70 ppm, sixtet centered at 1.0 ppm of
CH2 groups next to the CH3 groups, complex signals at about
1.10 ppm and at 1.25 due to CH2 groups attached to CH, and com-
plex signal at about 1.98 ppm of CH proton, having an intergration
ratio 6:4:2:2:1. The corresponding valproate proton signals of the
bis-adducts of caffeine or theophylline obtained in CDCl3 occur at
about 0.8, 1.1, 1.2, 1.35 and 2.1 ppm having an integration ratio
6:4:2:2:1. The results of the integrated spectrum of each of these
adducts indicated also that there are two molecules of caffeine or
theophylline per tetra (l-valproato) dirhodium (II) unit. This is
consistent with the analytical results in showing that rhodium
(II) valproate dimer forms bis-adducts in which two purine ligands
are occupying both axial positions.
Several coordination sites are available in theophylline and caf-
feine to bind metal ions. In addition to the nitrogen donor atoms,
and to carbonyl oxygens, it has been recently shown that these
purine bases can bind through C(8) atom [36]. To determine the
coordination site of theophylline and caffeine in complexes 4 and
5, respectively, 1H and 13C NMR (CDCl3) spectra of these complexes
are obtained and compared with those obtained for the parent pur-
ine ligands and the results are summarized in the Section 4. 1HC2 C4 C5 C6 C8
151.58 149.06 106.93 156.24 140.30
152.15 150.07 108.11 156.98 144.76
0.57 1.01 1.18 0.74 4.46
151.75 148.75 107.63 155.46 141.41
152.01 149.35 108.34 155.58 145.14
0.27 0.60 0.71 0.12 3.13
nd.
lipsoids represent thermal displacement parameters at the 30% probability level.
Fig. 2. View of the molecular structure of 5, showing the atom numbering scheme. Ellipsoids represent thermal displacement parameters at the 50% probability level.
Table 4
Selected bond distances (Å) and angles () for 5.
C(4)–O(2) 1.200(8) O(8)–C(25)–O(7) 126.3(6)
C(4)–N(4) 1.390(8) O(7)–C(25)–C(26) 116.0(7)
C(5)–N(4) 1.363(8) O(11)–C(41)–C(42) 118.2(6)
C(6)–N(2) 1.456(8) O(12)–C(41)–C(42) 115.6(6)
C(7)–N(3) 1.469(8) C(43)–C(42)–C(41) 115.8(7)
C(25)–O(7) 1.286(8) C(25)–O(7)–Rh(1) 119.1(4)
C(25)–C(26) 1.511(10) C(25)–O(8)–Rh(2) 118.2(4)
C(27)–C(28) 1.393(16) C(41)–O(11)–Rh(1) 119.0(4)
C(41)–O(12) 1.262(7) C(41)–O(12)–Rh(2) 118.8(4)
C(41)–C(42) 1.528(9) O(5)–Rh(1)–O(11) 176.07(17)
C(42)–C(46) 1.657(15) O(7)–Rh(1)–O(11) 90.59(18)
C(43)–C(44) 1.476(11) O(7)–Rh(1)–N(1) 94.81(18)
N(1)–Rh(1) 2.325(5) O(11)–Rh(1)–N(1) 97.71(18)
N(5)–Rh(2) 2.324(5) O(9)–Rh(1)–N(1) 89.05(17)
O(6)–Rh(2) 2.050(4) O(5)–Rh(1)–Rh(2) 88.28(12)
O(7)–Rh(1) 2.031(4) O(7)–Rh(1)–Rh(2) 87.54(12)
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shifts relative to the corresponding parent purine protons. For
complex 4, Dd 0.12 N(1)–CH3, 0.38 N(3)–CH3, 1.00 C(7)–H, 0.46
C(8)–H. Complex 5, Dd 0.12 N(1)–CH3, 0.41 N(3)–CH3, 0.13 N(7)–
CH3, 0.49 C(8)–H, see Section 4 and Table 2.
The highest proton shifts for complexes 4 and 5 are those of
C(8)–H and N(3)–CH3. 13C NMR spectra for these bis-adducts show
that all carbon resonances for the purine ligands in these adducts
are downﬁeld shifted relative to the corresponding resonances of
the parent purine. For complex 4, Dd 0.52 (N1CH3), 1.32 (N3CH3),
1.18 (C5), 4.46 (C8), 1.01 (C4), 0.57 (C2), 0.74 (C6). For complex
5, Dd 0.26 (N1CH3), 0.95 (N3CH3), 0.50 (N7CH3), 0.71 (C5), 3.13
(C8), 0.60 (C4), 0.27 (C2), 0.12 (C6), Section 4. An inspection of
these data indicate that the highest shifts are those for C(8) and
CH3 carbon of N(3)–CH3. These 1H and 13C results indicate that the-
ophylline or caffeine molecules in complexes 4 and 5, respectively,Table 3
Selected bond distances (Å) and angles () for 4.
O(1)–C(1) 1.227(4) C(8)–O(3)–Rh(1) 118.2(2)
C(1)–N(1) 1.398(4) C(8)–O(4)–Rh(1)#1 119.7(2)
C(1)–C(5) 1.406(5) C(16)–O(5)–Rh(1) 119.2(2)
C(2)–N(2) 1.368(4) C(16)–O(6)–Rh(1)#1 119.4(2)
C(3)–N(3) 1.360(4) O(3)–Rh(1)–O(6)#1 88.78(10)
C(8)–O(4) 1.261(4) O(3)–Rh(1)–O(4)#1 175.78(9)
C(11)–C(12) 1.495(7) O(6)#1–Rh(1)–O(4)#1 89.79(10)
C(16)–O(5) 1.264(4) O(3)–Rh(1)–O(5) 90.22(10)
C(16)–C(17) 1.515(6) O(6)#1–Rh(1)–O(5) 176.02(9)
N(3)–Rh(1) 2.303(3) O(4)#1–Rh(1)–O(5) 90.94(10)
N(7)–Rh(2) 2.309(3) O(3)–Rh(1)–N(3) 87.07(10)
O(3)–Rh(1) 2.029(2) O(6)#1–Rh(1)–N(3) 94.96(10)
O(4)–Rh(1)#1 2.036(2) O(4)#1–Rh(1)–N(3) 97.00(9)
O(5)–Rh(1) 2.042(2) O(5)–Rh(1)–N(3) 88.84(10)
O(10)–Rh(2)#2 2.028(3) O(3)–Rh(1)–Rh(1)#1 88.83(7)
O(11)–Rh(2) 2.037(3) O(6)#1–Rh(1)–Rh(1)#1 88.06(7)
Rh(2)–O(12)#2 2.031(3) O(4)#1–Rh(1)–Rh(1)#1 87.16(6)
Rh(1)–Rh(1)#1 2.3926(5) O(5)–Rh(1)–Rh(1)#1 88.07(7)
Rh(2)–Rh(2)#2 2.3936(7) N(3)–Rh(1)–Rh(1)#1 174.85(7)
O(8)–Rh(2) 2.042(4) O(11)–Rh(1)–Rh(2) 87.79(12)
O(9)–Rh(1) 2.046(4) O(9)–Rh(1)–Rh(2) 88.44(11)
O(10)–Rh(2) 2.043(4) N(1)–Rh(1)–Rh(2) 173.99(14)
O(11)–Rh(1) 2.035(4) O(12)–Rh(2)–Rh(1) 88.05(12)
Rh(1)–Rh(2) 2.3956(6) N(5)–Rh(2)–Rh(1) 175.44(13)bind to Rh2(valp)4 core through N(9). It is well-known that upon
metal coordination to purine ring nitrogen atoms, extensive p-
electron redistribution of the ring occurs, causing the protons
and carbons adjacent to the binding site more acidic and, thus,
experience downﬁeld chemical shifts [12]. The axial coordination
of two theophylline or caffeine molecules through N(9) to
Rh2(valp)4 core in solid state is conﬁrmed by X-ray crystal struc-
ture determination of the complexes 4 and 5, respectively.2.5. X-ray crystal structure determination of the complexes 4 and 5
View of the molecular structures for 4, and 5 with numbering
scheme are shown in Figs. 1 and 2, respectively. Selected bond
3594 A.L. Abuhijleh et al. / Journal of Organometallic Chemistry 694 (2009) 3590–3596distances and angles for the complexes are reported in Tables 3
and 4. The Rh(II) atoms in structures 4 and 5 are bridged by
carboxylate groups that span an average metal–metal bond
distance of 2.3936(7) and 2.3956(7) Å, respectively, which is very
similar to those of many dirhodium compounds [19]. Octahedral
coordination at Rh in complex 4 is completed by theophylline
moiety bound axially via the unprotected N(9) nitrogen atom
and by caffeine in complex 5 also via the unprotected N(9) nitro-
gen atom. The Rh–N bond distances in compound 4, 2.309(3) and
2.303(3), and 2.324(5) and 2.325(5) in 5 are larger than [dirho-
dium (acetato)4 (theophyline)2] complexes, 2.230(3), [dirhodium
(acetato)4 (caffeine)2] complexes, 2.315(9) [9] and dirhodium
bipyridine (bpy) compounds, 2.224(2) and 2.264(2) [19,23,34]
and almost similar to other dirhodium complexes [23]. The differ-
ence between Rh–N bond lengths in these complexes may be
attributed to steric hindrance between the axial ligands and the
substituted carboxylate groups; i.e. valproate is larger than the
acetate ions. On the other hand, the difference in the Rh–N bond
distance between (4 and 5) and dirhodium bpy compounds may
be attributed to the different binding modes of 4 and 5, mono-
dentate versus bidentate in dirhodium bpy compounds and other
bidentate N-ligands. As expected, the two axial Rh–N bonds are
much longer than the average Rh(1)–O and Rh(2)–O equatorial
bonds{2.035(4) Å}. The eq Rh–O bond distances are very similar
to those of other dirhodium carboxylate compounds [19,23,34].
The average bonding angles deviate slightly from those of an ideal
octahedron [23].3. Conclusion
Dirhodium tetravalproate Rh2(valp)4 interacts with theopylline
and caffeine to form the bis-adducts Rh2(valp)4L2. X-ray structural
analyses for these adducts showed that they are dimers with four
bridging carboxylates of the valproate ions between the two rho-
dium atoms and two N-purine ligands in the axial trans positions
with respect to the Rh–Rh bond. The Rh–Rh bond distances are
in the range expected for dirhodium tetracarboxylate complexes
[19]. The axial Rh–N bond distances in these adducts are longer
than, the corresponding bond distance in dirhodium tetraacetate
bis-adducts with these purines [9]. This is attributed to steric hin-
drance between the axial ligands and larger substituted alkyl car-
boxylate in valproate compare to the acetate. The axial
coordination through sterically hindered N(9) atom rather than
the preferred N(7) coordination site in theophylline (N(7) is
blocked in caffeine) may be attributed to electrostatic repulsion
between the exocyclic carbonyl oxygen O(6) of theophylline and
the carboxylate oxygen atoms of the valproate ligands [8,9]. If
the N(9) coordination site is blocked as in guanine and polyguany-
lic acid, these DNA nucleobases are not expected to interact with
dirhodium tetracarboxylates in the axial positions. It was reported
the guanine reacts with Rh2(O2CCH3)4(MeOH)2 by displacing one
or two equatorial acetate ligands to produce equatorially N(7)/
O(6) guanine bridging complexes [8,13,22]. The interaction of
Rh2(valp)4 with other purine bases and their corresponding
nucleosides and nucleotides are being investigated and the results
will be reported in due course.4. Experimental
4.1. Materials
Rhodium (III) chloride trihydrate, RhCl33H2O, sodium valpro-
ate, caffeine, theophylline, were from Sigma and CDCl3 was from
Aldrich.4.2. Synthesis
4.2.1. Synthesis of tetra (l-valproato) dirhodium (II), Rh2(valp)4 (1)
1.0 g of RhCl3.3H2O was dissolved in 50 ml of absolute ethanol
and saturated with sodium valproate. The resulting brick-red solu-
tion was reﬂuxed for 1.5 h. The dark-green solution which formed
was cooled to room temperature and ﬁltered to remove the excess
sodium valproate, the green ﬁltrate was left in the hood to evapo-
rate. The green precipitate that formed was washed with water and
dried in vacuo at about 110 C. 1H NMR (CDCl3): d 0.70 (t, 6H, CH3,
3JH–H = 6.9 Hz), 1.00 (sixt, 4H, CH2, 3JH–H = 7.1 Hz), 1.10–1.25 (m,
4H, CH2), 1.98 (m, 1H, CH). Anal. Calc. for C32H60O8Rh2: C, 49.37;
H, 7.71. Found: C, 49.55; H, 7.82%.
4.2.2. Synthesis of bis(theophylline)tetra(l-valproato)dirhodium(II),
Rh2(valp)4(ThH)2 (4)
Rh2(valp)4 (0.10 g, 0.13 mmol) and theophylline (0.047 g,
0.26 mmol) were stirred together at room temperature in absolute
ethanol (15 ml) for 2 h. The blue solution was ﬁltered and left in
the hood to evaporate. The violet precipitate that formed was
recrystallized from acetone to produce crystals suitable for X-ray
measurements. 1H NMR (CDCl3): d 0.80 (t, 6H, CH3, 3JH–H =
6.9 Hz), 1.10 (sixt, 4H, CH2, 3JH–H = 7.1 Hz), 1.20–1.35 (m, 4H,
CH2), 2.10 (m, 1H, CH), 8.30 (s, purine H(8)). 13C{1H} NMR (CDCl3):
d 29.05 (N1CH3), 31.60 (N3CH3), 108.11 (C5), 144.76 (C8), 150.07
(C4), 152.15 (C2), 156.98 (C6). Anal. Calc. for C46H76N8O12Rh2: C,
48.51; H, 6.68; N, 9.84. Found: C, 48.35: H, 6.55: N, 9.65%.
4.2.3. Synthesis of bis(caffeine)tetra(l-valproato)dirhodium(II),
Rh2(valp)4(Caf)2 (5)
Rh2(valp)4 (0.10 g, 0.13 mmol) and caffeine (0.05 g, 0.26 mmol)
were stirred together at room temperature in absolute ethanol
(15 ml). The initial green solution rapidly became purple which
was stirred for 3 h. The dark purple precipitate that formed was
recrystallized from acetone to produce crystals suitable for X-ray
measurements. 1H NMR (CDCl3): d 0.80 (t, 6H, CH3, 3JH–H =
6.9 Hz), 1.10 (sixt, 4H, CH2, 3JH–H = 7.1 Hz), 1.20–1.35 (m, 4H,
CH2), 2.10 (m, 1H, CH), 7.90 (s, purine H(8)). 13C{1H} NMR (CDCl3):
d 28.20 (N1CH3), 30.71 (N3CH3), 34.71 (N7CH3), 108.34 (C5),
145.14 (C8), 149.35 (C4), 152.01 (C2), 155.58 (C6). Anal. Calc. for
C48H80N8O12Rh2: C, 49.40; H, 6.86; N, 9.61. Found: C, 49.27; H,
6.71; N, 9.48%.
4.3. Physical measurements
Elemental analyses for C, H and N were performed by Galbraith
Laboratories, Knoxville, TN, USA. Electronic spectra of dichloro-
methane solutions were obtained with a Hewlett Pickard 8453
diode array spectrophotometer. IR spectral of Nujol mulls sealed
between polyethylene sheets were obtained in the 4000 to
200 cm1 region with a Perkin–Elmer model 843 IR spectropho-
tometer. 1H and 13C NMR measurements of the complexes in deu-
terated chloroform solutions were carried out at 298 K on a
600 MHz Bruker spectrometer. Chemical shifts were referenced
to SiMe4. Magnetic susceptibilities at room temperature were mea-
sured by the Gouy method.
4.3.1. X-ray crystallography
Single crystals suitable for X-ray measurements of the com-
plexes 4 and 5 were attached to a glass ﬁber, with epoxy glue,
and transferred to a Bruker SMART APEX CCD X-ray diffractometer
system controlled by a Pentium-based PC running the SMART soft-
ware package, [37] The crystal was mounted on the three-circle
goniometer with v ﬁxed at +54.76. The diffracted graphite-mono-
chromated Mo Ka radiation (k = 0.71073 Å) was detected on a
phosphor screen held at a distance of 6.0 cm from the crystal oper-
Table 5
Crystal data and structure reﬁnement for 4 and 5.
4 5
Formula C46H76N8O12Rh2 C48H80N8O12Rh2
Formula weight 1138.97 1167.02
Temperature (K) 173(1) 295(1)
Radiation Mo Ka, 0.71073 Å Mo Ka, 0.71073 Å
Crystal size (mm3) 0.37  0.22  0.09 0.19  0.18  0.16
crystal system triclinic triclinic
Space group P1 P1
a (Å) 12.3126(16) 13.6302(9)
b (Å) 13.2463(18) 18.0972(11)
c (Å) 18.247(3) 23.2958(15)
a () 72.108(2). 97.8940(10)
b () 73.264(2) 93.1610(10)
k () 73.048(2). 102.8210(10).
V (Å3) 2643.9(6) 5528.1(6)
Z 2 4
dcalc (g cm3) 1.431 1.402
F(0 0 0) 2440 2440
l (mm1) 0.689 0.661
h range () 1.77–26.00 1.57–27.00
Reﬂections collected 27 885 56 379
Independent reﬂections 10 340 [Rint = 0.0359] 23 707 [Rint = 0.0607]
h k l limits 15, 15/16, 16/22, 22 17, 17/22, 23/29, 29
Completeness to theta = 27.00 99.4% 98.2%
Absorption correction integration none
Maximum and minimum transmission 0.9406 and 0.7847 0.9017 and 0.8848
Reﬁnement method full-matrix least-squares on F2 full-matrix least-squares on F2
Data/restraints/parameters 10 340/0/633 23 707/0/1049
Goodness-of-ﬁt on F2 1.047 0.937
Final R indicesa [I>2sigma(I)] R1 = 0.0482, wR2 = 0.1128 R1 = 0.0703, wR2 = 0.1635
R indices (all data) R1 = 0.0582, wR2 = 0.1181 R1 = 0.1267, wR2 = 0.1840
Largest difference peak and hole (e Å3) 1.018 and 0.663 1.373 and 0.748
a R1 =
P
||Fo|  |Fc||/
P
Fo and wR2 = {
P
[w(F2o  F2c )2]/[w(F2o)2]}1/2.
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size of approximately 120 lm, was employed for data collection.
The detector centroid and crystal-to-detector distance were cali-
brated from a least-squares analysis of the unit cell parameters
of a carefully centered YLID reference crystal.
After the crystal of the complex had been carefully optically
centered within the X-ray beam, a series of 30 data frames mea-
sured at 0.3 increments of x were collected with three different
2h and u values to assess the overall crystal quality and to calculate
a preliminary unit cell. For the collection of the intensity data, the
detector was positioned at a 2h value of 28 and the intensity
images were measured at 0.3 intervals of x for duration of 20 s.
each. The data frames were collected in four distinct shells which,
when combined, measured more than 1.3 hemispheres of intensity
data with a maximum 2h of 46.5. Immediately after collection, the
raw data frames were transferred to a second PC computer for inte-
gration by the SAINT program package [38]. The background frame
information was updated according to the equation B0 = (7B + C)/8,
where B0 is the update pixel value, B is the background pixel value
before updating, and C is the pixel value in the current frame. The
integration was also corrected for spatial distortion induced by the
detector. In addition, pixels that reside outside the detector active
area or behind the beam stop were masked during frame integra-
tion. The integrated intensities for the four shells of data were
merged to one reﬂection ﬁle. The data ﬁle was ﬁltered to reject
outlier reﬂections. The rejection of a reﬂection was based on the
disagreement between the intensity of the reﬂection and the aver-
age intensity of the symmetry equivalents to which the reﬂection
belongs. In the case of strong reﬂections (I > 99r(I)) which contains
only two equivalents, the larger of the two equivalents was retains.
The structure was solved and reﬁned by the SHELXTL software pack-
age [39].
Crystal data and more details of the data collections and reﬁne-
ments are summarized in Table 5.Appendix A. Supplementary material
CDC 724336 and 724335 contains the supplementary crystallo-
graphic data for 4 and 5. These data can be obtained free of charge
from The Cambridge Crystallographic Data Centre via
www.ccdc.cam.ac.uk/data_request/cif.
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.jorganchem.2009.07.031.
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